Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants. (2021)
Attributed to:
A new noradrenergic strategy to treat Impulsivity in Progressive Supranuclear Palsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.72866
Publication URI: https://www.repository.cam.ac.uk/handle/1810/325410
Type: Journal Article/Review